Notes
Ce contenu est réservé aux abonnés
Bibliographie
- Ritter, A. & Pillai, J. A. Treatment of Vascular Cognitive Impairment. Curr Treat Options Neurol 17, 35–18 (2015).
- Gorelick, P. B. et al. Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 42, 2672–2713 (2011).
- Kumar, V., Anand, R., Messina, J., Hartman, R. & Veach, J. An efficacy and safety analysis of Exelon in Alzheimer’s disease patients with concurrent vascular risk factors. J. Neurol. 7, 159–169 (2000).
- Erkinjuntti, T. et al. Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomised trial. The Lancet 359, 1283–1290 (2002).
- Erkinjuntti, T. et al. An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia. Clin Ther 25, 1765–1782 (2003).
- Erkinjuntti, T., Roman, G. & Gauthier, S. Treatment of vascular dementia—evidence from clinical trials with cholinesterase inhibitors. Neurol Res. 26, 603–605 (2004).
- Roman, G. C. et al. Randomized, Placebo-Controlled, Clinical Trial of Donepezil in Vascular Dementia: Differential Effects by Hippocampal Size. Stroke 41, 1213–1221 (2010).
Fichiers
-
Fichier du cours pdf
